COVID’s Delta variant, a highly contagious, more infectious strain has led to increased transmissibility when compared with other variants and prompted the U.S. to renew the COVID-19 Public Health Emergency Declaration. Delta has caused an increased number of cases, including breakthrough cases in some vaccinated people, as well as rising hospitalizations, especially in regions with low vaccination rates.
During the past year, we were reminded of the critical role that supply chain plays in clinical care and overall operations. While our industry has adapted and grown to weather the COVID crisis, now is no time to return to business as usual. The roller coaster ride has slowed, but not stopped; supply chain still faces tremendous challenges such as product shortages, geo-political implications, increased costs, longer delivery times, worker shortages, lack of transparency, and other inventory challenges. Consider the following:
Topics: Supply Chain, Technology Trends, Equipment Planning, Clinical Excellence, Evidence-Based Medicine, Clinical Evidence Assessment, Evidence-based decision making, Value-based care, Best-practice evidence-based medicine
Healthcare administrators, value analysis, and clinical leaders constantly strive for greater performance, better clinical outcomes, and higher physician engagement. But while the need to nurture and achieve these priorities all at once remains strong, there is an underlying struggle on how to accomplish these distinct, yet interdependent goals.
Andrew Furman, MD, MMM, FACEP, Executive Director, Clinical Excellence at ECRI delved into these challenges as a featured speaker at the member-only 2021 Spring Vanguard Meeting of the American Association for Physician Leadership held on Friday, June 11.
Topics: Supporting Physicians, Clinical Excellence, Physician Engagement, Evidence-Based Medicine, Clinical Evidence Assessment, Evidence-based decision making, Value-based care, Best-practice evidence-based medicine